The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tolerability of lutetium-177–PSMA-617 in men with prostate cancer and baseline cytopenia.
 
Ahmad S Abdelrazek
No Relationships to Disclose
 
Ahmed Mahmoud
No Relationships to Disclose
 
Geoffrey Johnson
Leadership - Green Clinic (I); Nucleus RadioPharma (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Blue Earth Diagnostics (Inst); Curium Pharma (Inst); MedTrace (Inst); Morphimmune (Inst); Novartis (Inst); Siemens Healthineers (Inst); Viewpoint Molecular Targeting (Inst); Viewpoint Molecular Targeting (Inst); Z-Alpha (Inst)
Research Funding - Clarity Pharmaceuticals (Inst); Clovis Oncology (Inst); MedTrace (Inst); Novartis (Inst); Pfizer (Inst); Viewpoint Molecular Targeting (Inst); Viewpoint Molecular Targeting (Inst)
Patents, Royalties, Other Intellectual Property - Patents on Radiopharmaceuticals; Patents on Radiopharmaceuticals (Inst)
 
Derek R Johnson
No Relationships to Disclose
 
Corrie R Bach
No Relationships to Disclose
 
Jacob Orme
No Relationships to Disclose
 
Rodrigues Pessoa Rodrigo
No Relationships to Disclose
 
Reza Nabavizadeh
No Relationships to Disclose
 
Matthew Thorpe
No Relationships to Disclose
 
Eugene D. Kwon
No Relationships to Disclose
 
Ayse T. Kendi
No Relationships to Disclose
 
Daniel S Childs
Honoraria - IntrinsiQ; Targeted Oncology
Consulting or Advisory Role - Janssen Biotech (Inst)
Research Funding - Janssen Biotech (Inst)